Beyond inhaled medications: precision medicine and biologic therapies targeting the IL-33/TSLP/type 2 axis in COPD. [PDF]
Front ImmunolSong GQ, Chen B, He TL, Hu GQ.
europepmc +1 more source
A skin isolate of <i>Micrococcus luteus</i> negates the <i>Staphylococcus aureus-</i>induced release of type 2 cytokines from keratinocytes. [PDF]
Front ImmunolElias AE +4 more
europepmc +1 more source
Thymic stromal lymphopoietin (TSLP); TSLP receptor (TSLPR; CLRF2); IL-4; IL-13 [PDF]
Science-Business eXchange, 2008 openaire +1 more source
Multidimensional risk prediction model for infant atopic dermatitis: A prospective cohort study. [PDF]
World Allergy Organ JFan GZ, Hu LX, Liu MQ, Peng J, Qu ZH.
europepmc +1 more source
Mucosal Immunology in Health and Disease. 7th European Mucosal Immunology Group meeting Conference report [PDF]
, 2010 Vossenkämper, A
core
Effects of Tezepelumab in "United Airway Disease" (Asthma and CRSwNP). [PDF]
Case Rep PulmonolLupia C +9 more
europepmc +1 more source
Eosinophilic Esophagitis: Mechanisms of Disease and Approach to Treatment. [PDF]
Curr Allergy Asthma RepGautam R, Ruffner MA.
europepmc +1 more source
Palmitic acid aggravates atopic dermatitis by regulating SGK1/NEDD4L-involved cutaneous neuroimmune inflammation through driving TRPV1 and MRGPRB2 S-palmitoylation. [PDF]
Inflamm ResChen B +5 more
europepmc +1 more source
Potential of alarmin-targeted bispecific and combination therapies in airway disease. [PDF]
Front AllergyKomori HK, Ortega H.
europepmc +1 more source
[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 2: Hypersensitivity reactions of type V (epithelial barrier defects)]. [PDF]
HNOKlimek L +17 more
europepmc +1 more source